Due to frequent controversies involving the FDA, appointments are not always prompt and the agency is often headed by an acting commissioner. For example, the Andrew von Eschenbach's appointment was held up by senators who objected to the FDA's refusal to allow over the counter status to the controversial Plan Bemergency contraception.
The commissioner has frequently been a physician, but this is not a requirement for the post.